Why the study?
Does the systemic inflammatory response (CRP) predict inhospital mortality in patients with T2DM and STEMI undergoing primary PCI compared to those without diabetes?
Cohort (n=574)
No
Does the systemic inflammatory response (CRP) predict inhospital mortality in patients with T2DM and STEMI undergoing primary PCI compared to those without diabetes?
This study aims to evaluate the prognostic significance of CRP for inhospital mortality in STEMI patients with T2DM undergoing primary PCI.
Subjects with type 2 diabetes mellitus (T2DM) constitute 13-25% of patients with acute myocardial infarction with ST-segment elevation (STEMI) hospitalized for myocardial reperfusion therapy. The aim of this study was to evaluate systemic inflammatory respo-nse in patients with T2DM and STEMI undergoing primary angioplasty at our clinic and to estimate prognostic significance of inflammatory markers, C-reactive protein (CRP), for inhospital mortality in type 2 diabetics compared to those without diabetes.
No takes yet. Share an insight, caveat, or question.
Džudović et al. (2017) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=574). Elevated C-reactive protein (CRP) vs. Lower CRP levels was evaluated on In-hospital mortality / adverse outcome at 30 days (1.014, 95% CI 1.008-1.020, p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: